Treatment-resistant elephantiasic thyroid dermopathy responding to rituximab and plasmapheresis

Australasian Journal of Dermatology

Volumn 53, Issue 1, 2012, Pages e1-e4

  Heyes, Christopher ^a   Nolan, Richard ^a   Leahy, Michael ^a   Gebauer, Kurt ^a  

^a FREMANTLE HOSPITAL   (Australia)

Author keywords

elephantiasis; Graves' disease; plasmapheresis; pretibial myxoedema; rituximab; thyroid dermopathy

Indexed keywords

CYCLOPHOSPHAMIDE; ETRETIN; HYALURONIDASE; IMMUNOGLOBULIN; INFLIXIMAB; OCTREOTIDE; PREDNISOLONE; RADIOACTIVE IODINE; RITUXIMAB; THALIDOMIDE; THYROTROPIN;

ADULT; ARTICLE; CASE REPORT; CLUBBING FINGERS; COMPRESSION GARMENT; DISEASE COURSE; ELEPHANTIASIS; EXOPHTHALMOS; FEMALE; GRAVES DISEASE; HOARSENESS; HUMAN; HYPERKERATOSIS; HYPERTHYROIDISM; MULTIPLE CYCLE TREATMENT; MYXEDEMA; PHYSIOTHERAPY; PLASMAPHERESIS; SKIN DISEASE; THYROTROPIN BLOOD LEVEL; ULTRASOUND;

EID: 84856950073     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2010.00693.x     Document Type: Article

References (9)

1. Goette DK,. Thyroid acropachy. Arch. Dermatol. 1980; 166: 205-6. (Pubitemid 10176567)
2. Kriss JP,. Pathogenesis and treatment of pretibial myxedema. Endocrinol. Metab. Clin. North Am. 1987; 16: 409-15. (Pubitemid 18088084)
3. Fatourechi V, Pajouhi M, Fransway AF,. Dermopathy of Graves disease (pretibial myxedema): reviews of 150 cases. Medicine (Baltimore) 1994; 73: 1-7.
4. Schwartz KM, Fatourechi V, Ahmed DD, et al,. Dermopathy of Graves' disease (pretibial myxedema): long-term outcome. J. Clin. Endocrinol. Metab. 2002; 87: 438-46. (Pubitemid 34158200)
5. Noppakun N, Bancheun K, Chandraprasert S,. Unusual locations of localized myxedema in Graves' disease. Report of three cases. Arch. Dermatol. 1986; 122: 85-8. (Pubitemid 16063273)
6. Akasu F, Takazawa K, Akasu R, et al,. Localized myxedema on the nasal dorsum in a patient with Graves' disease: report of a case. J. Endocrinol. Invest. 1989; 12: 717-21. (Pubitemid 20013851)
7. El Fassi D, Nielson C, Bonnema S, et al,. B Lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study. J. Clin. Endocrinol. Metab. 2007; 92: 1769-72. (Pubitemid 46997186)
8. Salvi M, Vannucchi G, Campi I, et al,. Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. Eur. J. Endocrinol. 2007; 156: 33-40. (Pubitemid 46553901)
9. Fatourechi M, Rokea A, Gibson L,. Rituximab: applications in dermatology. Int. J. Dermatol. 2006; 45: 1143-55. (Pubitemid 44560360)